Judit Hodrea

711 total citations
26 papers, 558 citations indexed

About

Judit Hodrea is a scholar working on Molecular Biology, Immunology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Judit Hodrea has authored 26 papers receiving a total of 558 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 6 papers in Immunology and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in Judit Hodrea's work include Pharmacological Receptor Mechanisms and Effects (8 papers), Receptor Mechanisms and Signaling (7 papers) and Neuropeptides and Animal Physiology (5 papers). Judit Hodrea is often cited by papers focused on Pharmacological Receptor Mechanisms and Effects (8 papers), Receptor Mechanisms and Signaling (7 papers) and Neuropeptides and Animal Physiology (5 papers). Judit Hodrea collaborates with scholars based in Hungary, Denmark and Vietnam. Judit Hodrea's co-authors include Andrea Fekete, Attila J. Szabó, Ádám Hosszú, Lilla Lénárt, Dóra Balogh, László Fésüs, László Wagner, Gyöngyike Májai, Ádám Vannay and Federica Genovese and has published in prestigious journals such as PLoS ONE, The Journal of Physiology and Diabetes.

In The Last Decade

Judit Hodrea

25 papers receiving 550 citations

Peers

Judit Hodrea
Stefania Bellini Italy
Tamara Ramadan Switzerland
Qian Ma China
Emma Assi Italy
Changhong Miao China
Antonella La Russa Italy
Jianchun Liao China
Anna Hammer Germany
Yue He China
Katharina Völker Germany
Stefania Bellini Italy
Judit Hodrea
Citations per year, relative to Judit Hodrea Judit Hodrea (= 1×) peers Stefania Bellini

Countries citing papers authored by Judit Hodrea

Since Specialization
Citations

This map shows the geographic impact of Judit Hodrea's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Judit Hodrea with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Judit Hodrea more than expected).

Fields of papers citing papers by Judit Hodrea

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Judit Hodrea. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Judit Hodrea. The network helps show where Judit Hodrea may publish in the future.

Co-authorship network of co-authors of Judit Hodrea

This figure shows the co-authorship network connecting the top 25 collaborators of Judit Hodrea. A scholar is included among the top collaborators of Judit Hodrea based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Judit Hodrea. Judit Hodrea is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Balogh, Dóra, et al.. (2024). Sigma-1 Receptor as a Novel Therapeutic Target in Diabetic Kidney Disease. International Journal of Molecular Sciences. 25(24). 13327–13327. 1 indexed citations
2.
3.
Hodrea, Judit, et al.. (2023). Sigma-1 Receptor Agonist Fluvoxamine Ameliorates Fibrotic Response of Trabecular Meshwork Cells. International Journal of Molecular Sciences. 24(14). 11646–11646. 3 indexed citations
4.
Balogh, Dóra, Lilla Lénárt, Ádám Hosszú, et al.. (2023). 10-LB: Activation of Sigma-1 Receptor as a Novel Therapeutic Target in Diabetic Kidney Disease. Diabetes. 72(Supplement_1). 1 indexed citations
5.
Hodrea, Judit, Attila Fintha, László Wagner, et al.. (2022). SGLT2 inhibitor dapagliflozin prevents atherosclerotic and cardiac complications in experimental type 1 diabetes. PLoS ONE. 17(2). e0263285–e0263285. 28 indexed citations
6.
Hosszú, Ádám, Beáta Szebeni, László Őrfi, et al.. (2021). Lyophilization and homogenization of biological samples improves reproducibility and reduces standard deviation in molecular biology techniques. Amino Acids. 53(6). 917–928. 40 indexed citations
7.
Balogh, Dóra, Judit Hodrea, Ádám Hosszú, et al.. (2021). MO620ANTIFIBROTIC EFFECTS OF SGLT2 INHIBITION IN THE KIDNEY AND PROXIMAL TUBULAR CELLS*. Nephrology Dialysis Transplantation. 36(Supplement_1). 1 indexed citations
8.
Hodrea, Judit, Dóra Balogh, Ádám Hosszú, et al.. (2020). Reduced O-GlcNAcylation and tubular hypoxia contribute to the antifibrotic effect of SGLT2 inhibitor dapagliflozin in the diabetic kidney. American Journal of Physiology-Renal Physiology. 318(4). F1017–F1029. 40 indexed citations
9.
Lénárt, Lilla, Dóra Balogh, Nikolett Lénárt, et al.. (2019). Novel therapeutic potential of angiotensin receptor 1 blockade in a rat model of diabetes-associated depression parallels altered BDNF signalling. Diabetologia. 62(8). 1501–1513. 19 indexed citations
10.
Lénárt, Lilla, Judit Hodrea, Dóra Balogh, et al.. (2018). RAAS inhibitors directly reduce diabetes‐induced renal fibrosis via growth factor inhibition. The Journal of Physiology. 597(1). 193–209. 73 indexed citations
11.
Hosszú, Ádám, Zsuzsanna Antal, Lilla Lénárt, et al.. (2018). The role of Sigma-1 receptor in sex-specific heat shock response in an experimental rat model of renal ischaemia/reperfusion injury. Transplant International. 31(11). 1268–1278. 17 indexed citations
12.
Lénárt, Lilla, Judit Hodrea, Ádám Hosszú, et al.. (2016). The role of sigma-1 receptor and brain-derived neurotrophic factor in the development of diabetes and comorbid depression in streptozotocin-induced diabetic rats. Psychopharmacology. 233(7). 1269–1278. 21 indexed citations
13.
Nemcsik, János, Lilla Lénárt, Péter Torzsa, et al.. (2016). Hyperthymic affective temperament and hypertension are independent determinants of serum brain-derived neurotrophic factor level. Annals of General Psychiatry. 15(1). 17–17. 22 indexed citations
14.
Hodrea, Judit, Lilla Lénárt, Ádám Hosszú, et al.. (2016). Role ofO-linkedN-acetylglucosamine modification in diabetic nephropathy. American Journal of Physiology-Renal Physiology. 311(6). F1172–F1181. 38 indexed citations
15.
Csomós, Krisztián, Endre Kristóf, Judit Hodrea, et al.. (2016). Protein cross-linking by chlorinated polyamines and transglutamylation stabilizes neutrophil extracellular traps. Cell Death and Disease. 7(8). e2332–e2332. 29 indexed citations
16.
Eőry, Ajándék, László Kalabay, Xénia Gonda, et al.. (2015). Identification of hypertensive patients with dominant affective temperaments might improve the psychopathological and cardiovascular risk stratification: a pilot, case–control study. Annals of General Psychiatry. 14(1). 33–33. 12 indexed citations
17.
Petrovski, Goran, Gyöngyike Májai, Judit Hodrea, et al.. (2011). Phagocytosis of cells dying through autophagy induces inflammasome activation and IL-1β release in human macrophages. Autophagy. 7(3). 321–330. 55 indexed citations
18.
Hodrea, Judit, Gyöngyike Májai, Gábor Zahuczky, et al.. (2011). The glucocorticoid dexamethasone programs human dendritic cells for enhanced phagocytosis of apoptotic neutrophils and inflammatory response. Journal of Leukocyte Biology. 91(1). 127–136. 23 indexed citations
19.
Hodrea, Judit, Máté Demény, Gyöngyike Májai, et al.. (2009). Transglutaminase 2 is expressed and active on the surface of human monocyte-derived dendritic cells and macrophages. Immunology Letters. 130(1-2). 74–81. 38 indexed citations
20.
Takátsy, Anikó, Judit Hodrea, Cornelia Majdik, Florin Dan Irimie, & Ferenc Kilár. (2006). Role of chemical structure in molecular recognition by transferrin. Journal of Molecular Recognition. 19(4). 270–274. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stefania Bellini Breakdown of academic impact, for papers by Tamara Ramadan Breakdown of academic impact, for papers by Qian Ma Breakdown of academic impact, for papers by Emma Assi Breakdown of academic impact, for papers by Changhong Miao Breakdown of academic impact, for papers by Antonella La Russa Breakdown of academic impact, for papers by Jianchun Liao Breakdown of academic impact, for papers by Anna Hammer Breakdown of academic impact, for papers by Yue He Breakdown of academic impact, for papers by Katharina Völker
Rankless by CCL
2026